Latest News Archive
Please select Category, Year, and then Month to display items
03 March 2021
|
Story Giselle Baillie
|
Photo Supplied
_web.jpg?sfvrsn=987e6620_1 "NJ van Merwe Read More (1)_web")
Residence members who led the project, included:
Bohlokwa Rantja, the Residence Prime, and Transformation Committee members Nsuku Mutemela, Ofentse Motlakeng, Phindile Tjale, Madinku Mabala, Mmapopi Motshoso, Karabo Shuping, and Tagane Sekete.
The University of the Free State (UFS) Council approved and adopted Lehakwe House as the new name for the
NJ van der Merwe residence on the Bloemfontein Campus. The approval on 26 November 2020 followed a lengthy process of deliberation, consultation, and public engagement that has taken place since November 2019 and is aligned with the UFS Policy on Naming and Renaming. The name-change process was initiated by the Prime and Transformation Committee of the residence, guided by the
Unit for Institutional Change and Social Justice and supported by a multi-stakeholder committee representative of the residence, the Housing and Residence Affairs Office, the Department of Student Affairs, the Student Representative Council, and alumni.
Lehakwe – a precious gem
Following a lengthy evaluation process of the names submitted through a public voting and recommendation platform in July 2020, ‘Lehakwe’ – a Sesotho word referring to a ‘precious gem’ – emerged as the front runner. As many current and past members of the residence attest, this womxn’s residence has come to occupy a significant space within the hearts and minds of UFS students and the UFS community, given that its spirit has always been closely aligned with the constitutional values of dignity, equality, and freedom and with the human values of ubuntu. In this vein, the new name of ‘Lehakwe’ presents a consolidation of constitutional and university values into the day-to-day thinking, learning, living, and legacy spaces of students, as well as everyone who interacts and engages with the UFS.
UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08
The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.
The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.
The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.
“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.
“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.
According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.
The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.
According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.
The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.
Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004